Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.0:00 Introduction 0:53 What is CRISPR?2:05 How Does CRISPR work?3:18 The Experiment5:30 The Results9:31 ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its ...

CRISPRgenee is a new method that combines gene silencing and cutting to improve loss-of-function studies in human cells.

Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics (NASDAQ:CRSP), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Researchers engineered a CRISPR base editor to correct the ACTA2 mutation causing multisystemic smooth muscle dysfunction ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...